Filing Details

Accession Number:
0000711377-20-000025
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-07 10:40:20
Reporting Period:
2020-08-05
Accepted Time:
2020-08-07 10:40:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1790610 Warren Jason Lilly 620 Lesher Place
Lansing MI 48912
Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-08-05 5,681 $62.70 16,090 No 4 M Direct
Common Stock Disposition 2020-08-05 5,681 $80.08 10,409 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2020-08-05 5,681 $0.00 5,681 $62.70
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
103,667 2023-12-01 No 4 M Direct
Footnotes
  1. Options were issued on 11/1/2018, have five year lives, and vest in equal 20% annual installments on each of the anniversary dates of the grant